Neostigmine (Prostigmin, Neostigmine)
Dosage form:
Injectable solution 0.5 mg/mL; tablets 15 mg
Pharmacological group:
Cholinesterase inhibitor
Therapeutic use:
Treatment and diagnosis of myasthenia gravis
Dosage:
Dogs:
Treatment of myasthenia gravis: 0.04 mg/kg intramuscularly or subcutaneously every 6 hours.
Diagnosis of myasthenia gravis: 0.04 mg/kg intramuscularly or subcutaneously, or 0.02 mg/kg intravenously.
Diagnosis of myasthenia gravis: 0.04 mg/kg intramuscularly or subcutaneously, or 0.02 mg/kg intravenously.